Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1972 Aug 5;107(3):213–216.

The influence of serum triglycerides on the fate of aorto-coronary vein grafts

C Allard, O Ruscito, C Goulet
PMCID: PMC1940877  PMID: 5052905

Abstract

Fasting blood lipids were analyzed shortly before revascularization surgery in an attempt to find a possible correlation between the fate of the aortocoronary saphenous vein graft and lipoproteinemia. The patency of the bypass was evaluated by arteriography at two weeks and at one year following operation. Patients with closed grafts at two weeks had an original mean serum triglyceride concentration of 287 mg./100 ml. Patients with grafts which were widely patent after one year had an original triglyceridemia of 224 mg./100 ml. The severely stenosed group had an intermediate average preoperative value of 224 mg./100 ml. The same conclusion was reached with a group of patients with good vessel(s) distal to the graft(s). Cholesterolemia was about the same in all groups. These results suggest the hypothesis that hypertriglyceridemia plays a significant role in the reduction and/or occlusion of the lumen of the vein graft.

Full text

PDF
213

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allard C., Ruscito O., Goulet C. Preoperative serum lipid profile in surgically treated patients with coronary arteriosclerosis. Surg Gynecol Obstet. 1971 Nov;133(5):807–811. [PubMed] [Google Scholar]
  2. Bourassa M. G., Lespérance J., Campeau L. Selective coronary arteriography by the percutaneous femoral artery approach. Am J Roentgenol Radium Ther Nucl Med. 1969 Oct;107(2):377–383. doi: 10.2214/ajr.107.2.377. [DOI] [PubMed] [Google Scholar]
  3. Epstein S. E., Brakman P., Rosing D. R., Redwood D. R. Impaired fibrinolytic response to exercise in patients with type-IV hyperlipoproteinaemia. Lancet. 1970 Sep 26;2(7674):631–634. doi: 10.1016/s0140-6736(70)91399-1. [DOI] [PubMed] [Google Scholar]
  4. GREIG H. B., RUNDE I. A. Studies on the inhibition of fibrinolysis by lipids. Lancet. 1957 Sep 7;273(6993):461–464. doi: 10.1016/s0140-6736(57)90769-9. [DOI] [PubMed] [Google Scholar]
  5. Grace C. S., Goldrick R. B. Fibrinolysis and body bulid. Interrelationships between blood fibrinolysis, body composition and parameters of lipid and carbohydrate metabolism. J Atheroscler Res. 1968 Jul-Aug;8(4):705–719. doi: 10.1016/s0368-1319(68)80028-6. [DOI] [PubMed] [Google Scholar]
  6. Marti M. C., Bouchardy B., Cox J. N. Aorto-coronary by-pass with autogenous saphenous vein grafts: histopathological aspects. Virchows Arch A Pathol Pathol Anat. 1971;352(3):255–266. doi: 10.1007/BF00600675. [DOI] [PubMed] [Google Scholar]
  7. SARKAR N. Reduced fibrinolytic activity of atherosclerotic sera caused by an increase in low-density lipoproteins in blood. Nature. 1961 Mar 18;189:929–931. doi: 10.1038/189929a0. [DOI] [PubMed] [Google Scholar]
  8. Vlodaver Z., Edwards J. E. Pathologic changes in aortic-coronary arterial saphenous vein grafts. Circulation. 1971 Oct;44(4):719–728. doi: 10.1161/01.cir.44.4.719. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES